サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413312

陽子線治療市場：システムタイプ、用途、エンドユーザー別-2024-2030年の世界予測

Proton Therapy Market by System Type (Multi-Room System, Single Room System), Application (Colorectal Cancer, Lung Cancer, Pediatric Cancer), End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
陽子線治療市場：システムタイプ、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

陽子線治療市場規模は、2023年に5億5,371万米ドルと推定され、2024年には6億2,356万米ドルに達し、CAGR 14.38%で2030年には14億1,854万米ドルに達すると予測されています。

陽子線治療の世界市場

主な市場の統計
基準年[2023］ 5億5,371万米ドル
予測年 [2024] 6億2,356万米ドル
予測年 [2030] 14億1,854万米ドル
CAGR（%） 14.38%
陽子線治療 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは陽子線治療市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、陽子線治療市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-陽子線治療市場の市場規模および予測は？

2-陽子線治療市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-陽子線治療市場における技術動向と規制の枠組みは？

4-陽子線治療市場における主要ベンダーの市場シェアは？

5-陽子線治療市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • がん患者数の増加に伴うタバコ消費量の増加
      • 高齢者人口の増加に伴い、人々の平均寿命は延びる
      • 陽子線治療の人気の高まり
    • 抑制要因
      • 陽子線治療センターの設置には高額な費用がかかる
      • 償還ポリシーの欠如
    • 機会
      • 発展途上市場における陽子線治療調査プログラムの数の増加
      • がん治療の治療システムにおける技術の進歩
    • 課題
      • 新興経済における陽子線治療に関する患者の認識の欠如
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 陽子線治療市場システムタイプ別

  • マルチルームシステム
  • 個室システム

第7章 陽子線治療市場：用途別

  • 結腸直腸がん
  • 肺がん
  • 小児がん
  • 前立腺がん

第8章 陽子線治療市場：エンドユーザー別

  • 外来手術センター
  • 病院
  • 専門クリニック

第9章 南北アメリカの陽子線治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の陽子線治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの陽子線治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Accuray Incorporated
    • Advanced Oncotherapy PLC
    • Hitachi Ltd.
    • Ion Beam Applications SA
    • Koninklijke Philips N.V.
    • Mevion Medical Systems, Inc.
    • Mitsubishi Electric Corporation
    • Optivus Proton Therapy, Inc.
    • ProNova Solutions, LLC
    • ProTon International
    • Protonic Medical Systems Private Limited
    • Provision Healthcare, LLC
    • PTW Freiburg GmbH
    • Radiological Society of North America, Inc
    • RaySearch Laboratories AB
    • Sumitomo Heavy Industries Ltd.
    • Thermo Fisher Scientific, Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PROTON THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PROTON THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. PROTON THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PROTON THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. PROTON THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PROTON THERAPY MARKET DYNAMICS
  • FIGURE 7. PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2030 (%)
  • FIGURE 8. PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. PROTON THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. PROTON THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. PROTON THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. PROTON THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PROTON THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. PROTON THERAPY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. PROTON THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. PROTON THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROTON THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PROTON THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PROTON THERAPY MARKET SIZE, BY SINGLE ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. PROTON THERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PROTON THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PROTON THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PROTON THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. PROTON THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PROTON THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PROTON THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. PROTON THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 145. PROTON THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. PROTON THERAPY MARKET LICENSE & PRICING
目次
Product Code: MRR-0309E83AC43C

[198 Pages Report] The Proton Therapy Market size was estimated at USD 553.71 million in 2023 and expected to reach USD 623.56 million in 2024, at a CAGR 14.38% to reach USD 1,418.54 million by 2030.

Global Proton Therapy Market

KEY MARKET STATISTICS
Base Year [2023] USD 553.71 million
Estimated Year [2024] USD 623.56 million
Forecast Year [2030] USD 1,418.54 million
CAGR (%) 14.38%
Proton Therapy Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Proton Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Proton Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Proton Therapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Advanced Oncotherapy PLC, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems, Inc., Mitsubishi Electric Corporation, Optivus Proton Therapy, Inc., ProNova Solutions, LLC, ProTon International, Protonic Medical Systems Private Limited, Provision Healthcare, LLC, PTW Freiburg GmbH, Radiological Society of North America, Inc, RaySearch Laboratories AB, Sumitomo Heavy Industries Ltd., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Proton Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • System Type
    • Multi-Room System
    • Single Room System
  • Application
    • Colorectal Cancer
    • Lung Cancer
    • Pediatric Cancer
    • Prostate Cancer
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Proton Therapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Proton Therapy Market?

3. What are the technology trends and regulatory frameworks in the Proton Therapy Market?

4. What is the market share of the leading vendors in the Proton Therapy Market?

5. Which modes and strategic moves are suitable for entering the Proton Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Proton Therapy Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in tobacco consumption along with increase in number of cancer patients
      • 5.1.1.2. Increasing life expectancy of people along with rise in geriatric population
      • 5.1.1.3. Growing popularity of proton therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost required for the installation of proton therapy centre
      • 5.1.2.2. Lack of reimbursement policy
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of proton therapy research programs in the developing market
      • 5.1.3.2. Technological advancement in therapeutic systems of cancer treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness in patients about proton therapy in the emerging economy
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Proton Therapy Market, by System Type

  • 6.1. Introduction
  • 6.2. Multi-Room System
  • 6.3. Single Room System

7. Proton Therapy Market, by Application

  • 7.1. Introduction
  • 7.2. Colorectal Cancer
  • 7.3. Lung Cancer
  • 7.4. Pediatric Cancer
  • 7.5. Prostate Cancer

8. Proton Therapy Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Proton Therapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Proton Therapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Proton Therapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Accuray Incorporated
    • 13.1.2. Advanced Oncotherapy PLC
    • 13.1.3. Hitachi Ltd.
    • 13.1.4. Ion Beam Applications SA
    • 13.1.5. Koninklijke Philips N.V.
    • 13.1.6. Mevion Medical Systems, Inc.
    • 13.1.7. Mitsubishi Electric Corporation
    • 13.1.8. Optivus Proton Therapy, Inc.
    • 13.1.9. ProNova Solutions, LLC
    • 13.1.10. ProTon International
    • 13.1.11. Protonic Medical Systems Private Limited
    • 13.1.12. Provision Healthcare, LLC
    • 13.1.13. PTW Freiburg GmbH
    • 13.1.14. Radiological Society of North America, Inc
    • 13.1.15. RaySearch Laboratories AB
    • 13.1.16. Sumitomo Heavy Industries Ltd.
    • 13.1.17. Thermo Fisher Scientific, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing